From: Differential effects of KRAS mutational status on long-term survival according to the timing of colorectal liver metastases
KRAS-wt
n = 26
KRAS-mut
n = 23
P-value
Total cohort
15/26 (57.7%)
8/23 (34.8%)
0.154
Synchronous metastases
10/15 (66.7%)
2/14 (14.3%)
0.008
Metachronous metastases
5/11 (45.5%)
6/9 (66.7%)
0.406